Virtify

About:

Virtify provides structured content management and regulatory information management solutions for life sciences.

Website: http://www.virtify.com

Twitter/X: virtifyinc

Top Investors: Tudor Growth Equity

Description:

Virtify, Inc. provides enterprise content compliance solutions for the life sciences industry. It offers regulatory compliance products, such as Virtx SPL, a Web based application for organizations to meet the SPL and PLR standards; Virtx electronic common technical document (eCTD), a Web-based application to author, compile, review, QC, publish, and transmit eCTDs; and Virtx Clinical Trial Registry and Results, a clinical trial disclosure solution for compliance automation and management. The company also provides Virtx Product Information Management solution for the electronic exchange of product information in the context of marketing authorization applications; Virtx RPS for supporting health level 7 (HL7) regulated product submission standards; and Virtx eStability to support HL7 electronic drug stability standards. In addition, it offers enterprise eCompliance and clinical trials management software products, including Virtx Structured Content Management, a Web-based application for document authoring, reviewing, assembly, publishing, and delivery; Virtx Core Data Sheet, a Web-based application for managing a company's data sheets, including change notifications and response tracking; Virtx Submissions Tracker, a Web-based application for submissions tracking and planning; and Investigator Database, a clinical trials data management software. Further, the company provides Virtx RIS, a regulatory information solution platform for organizational-specific regulatory operations information; Virtx RMA for Web-based resource management and tracking; Virtx IDM, an investigator clinical trials management solution; and Virtx PRS, a patient registry/clinical trial management solution. Further more, it offers professional services for clinical data management, submission, validation, custom development, applications development, maintenance, system integration, product support, and education services. The company is based in Cambridge, Massachusetts.

Total Funding Amount:

$25.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2009-01-01

Founders:

Satish Tadikonda

Number of Employees:

51-100

Last Funding Date:

2013-03-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai